Sign In
Buy MRTX
$58.70
+0 (+0%)
At Close: Apr 19, 2024
Mirati Therapeutics down 6% as Kerrisdale shorts
02:39pm, Tuesday, 21'st Apr 2020
Kerrisdale Capital reports that it is short Mirati Therapeutics (MRTX -5.9%) based on, what it considers, dim prospects for lead drug MRTX-849, citing early-stage data showing a low response rate and
President Trump said he has asked that Federal funds be made available to oil companies
02:35pm, Tuesday, 21'st Apr 2020
President Trump said he has asked that Federal funds be made available to oil companies
Nordic American Tankers call volume above normal and directionally bullish NAT
02:35pm, Tuesday, 21'st Apr 2020
Nordic American Tankers call volume above normal and directionally bullish NAT
MiMedx announces notice that PPP loan application has been approved MDXG
02:35pm, Tuesday, 21'st Apr 2020
MiMedx announces notice that PPP loan application has been approved MDXG
BioSig's ViralClear submits application for Vicromax through CTAP BSGM
02:35pm, Tuesday, 21'st Apr 2020
BioSig's ViralClear submits application for Vicromax through CTAP BSGM
Hoth Therapeutics Z-ood data shows lesion improvement in CLE study HOTH
02:35pm, Tuesday, 21'st Apr 2020
Hoth Therapeutics Z-ood data shows lesion improvement in CLE study HOTH
NASDAQ market internals summary $NSD
02:35pm, Tuesday, 21'st Apr 2020
NASDAQ market internals summary $NSD
Moderna CMV vaccine candidate development reasonable, says Oppenheimer MRNA
02:35pm, Tuesday, 21'st Apr 2020
Moderna CMV vaccine candidate development reasonable, says Oppenheimer Oppenheimer MRNA
NYSE market internals summary $NYE
02:35pm, Tuesday, 21'st Apr 2020
NYSE market internals summary $NYE
U.S. existing home sales dropped -8.5% in March to 5.270 M
02:34pm, Tuesday, 21'st Apr 2020
U.S. existing home sales dropped -8.5% in March to 5.270 M
Credit Suisse analysts to hold an analyst/industry conference call
02:34pm, Tuesday, 21'st Apr 2020
Credit Suisse analysts to hold an analyst/industry conference call
Cinedigm reports 9.4M monthly active ad-supported viewers in March CIDM
02:34pm, Tuesday, 21'st Apr 2020
Cinedigm reports 9.4M monthly active ad-supported viewers in March CIDM
Mirati slides as short-seller says oncology drugs 'destined for futility' MRTX
02:34pm, Tuesday, 21'st Apr 2020
Mirati slides as short-seller says oncology drugs 'destined for futility' MRTX
Mirati Therapeutics Inc (NASDAQ:MRTX) CEO Charles M. Baum Sells 40,000 Shares
08:24am, Tuesday, 21'st Apr 2020
Mirati Therapeutics Inc (NASDAQ:MRTX) CEO Charles M. Baum sold 40,000 shares of Mirati Therapeutics stock in a transaction dated Friday, April 17th. The stock was sold at an average price of $90.33, f
JonesTrading Keeps Their Buy Rating on Mirati Therapeutics (MRTX)
05:04pm, Monday, 20'th Apr 2020
JonesTrading analyst Soumit Roy reiterated a Buy rating on Mirati Therapeutics (MRTX) today and set a price target of $130.00. The company's shares closed
